Effects of Bitter Melon Saponin on the Glucose and Lipid Metabolism in HepG2 Cell and <i>C. elegans</i>

Bai, Juan; Zhu, Ying; Li, Jie; Zhang, Yi; Dong, Ying; Xiao, Xiang

doi:https://doi.org/10.1155/2020/8860356

Journal of Food Quality

On this page

Abstract Introduction Materials and Methods Results and Discussion Conclusions Data Availability Conflicts of Interest Acknowledgments References Copyright Related Articles

Special Issue

Bioactive Food Components and their Chronic Diseases Prevention Effects

View this Special Issue

Research Article | Open Access

Volume 2020 | Article ID 8860356 | https://doi.org/10.1155/2020/8860356

Effects of Bitter Melon Saponin on the Glucose and Lipid Metabolism in HepG2 Cell and C. elegans

Juan Bai,¹Ying Zhu,¹Jie Li,¹Yi Zhang,¹Ying Dong,¹and Xiang Xiao^1,2

Academic Editor: Quancai Sun

Received20 May 2020

Revised30 May 2020

Accepted05 Jun 2020

Published24 Jun 2020

Abstract

This study tried to explore how saponins from bitter melon (BMS) affect the glucose and lipid metabolism in palmitic acid-treated HepG2 cell and glucose-treated Caenorhabditis elegans (C. elegans). Results showed that BMS could effectively accelerate glucose consumption and elevate the levels of glycogen and ATP in palmitic acid-treated HepG2 cell, while significantly decreasing the triglyceride (TG) content. qRT-PCR data indicated that BMS might promote fatty acid β-oxidation by AMPK-ACC2-CPT1 pathway and glucose uptake by upregulating GLUT4 expression. In the model of glucose-treated C. elegans, we observed that BMS obviously inhibited fat accumulation, along with no toxicity towards some physical activities. The potential mechanism of BMS in the metabolism involved the suppression of synthesis of polyunsaturated fatty acids and enhancement of fatty acid β-oxidation. Taken together, BMS exhibited ability of regulating energy metabolism in HepG2 cell line and C. elegans.

1. Introduction

In the last few decades, obesity and its related metabolic disorders have emerged as public health issues worldwide [1]. Obesity is developed with the evidence of body weight gain, insulin resistance, hyperlipaemia, and so on, increasing the risk of II type diabetes, nonalcoholic fatty liver disease, and some other metabolic syndromes [2]. Nowadays, much attention has been paid to some natural nutrients to early intervene the obesity. Bitter melon (Momordica charantia L.) is commonly used as a medicinal and edible plant for disease prevention, particularly obesity and diabetes [3]. Saponin is one of the main active components in bitter melon, whose structure consists of triterpenes and steroids [4]. Large amounts of mechanism studies have shown that the saponins of bitter gourd have physiological activities such as lowering blood glucose and improving insulin resistance, which are recognized as insulin-like [5, 6]. What is more, the fat-lowering effect of BMS is another bioactivity, which interacts with the glucose metabolism to improve the insulin resistance. In vitro study suggested bitter melon triterpenoid reduced preadipocyte viability and lipid accumulation by downregulating PPARγ in 3T3-L1 cells [7]; in vivo study reported that saponin extract from bitter melon significantly suppressed body weight gain and visceral fat accumulation in the PPARα- and PPARγ-mediated pathways in obese mice [8].

Caenorhabditis elegans (C. elegans, also referred to as ‘nematode’ hereinafter), is a whole-system organism for the evaluation and mechanism study of toxicity or bioactivity. Recently, C. elegans has become an excellent model for studying the mechanism of lipid metabolism due to its high homology to mammals and rich genes-deficient mutants [9]. Lipid metabolism includes fatty acid synthesis, oxidation, unsaturation, and elongation, which are deeply evolutionarily conserved in C. elegans to the mammals. Additionally, in the obese, liver is one of the important insulin-sensitive tissues and HepG2 cell line is commonly applied to study the lipid metabolism in hepatic function by stimulation with fatty acids.

Therefore, this study aimed to figure out the impacts of BMS on ameliorating insulin sensitivity and fat deposition in hepatic cell. Based on this, we further confirm the fat-lowering effects of BMS in C. elegans and preliminarily reveal the potential mechanism in the models we used in this current study.

2. Materials and Methods

2.1. Materials and Chemicals

Fresh bitter melons were collected from Lvjian Agricultural Station (Yangzhong City, China) and authenticated by Jiangsu Academy of Agricultural Science. HepG2 cell was purchased from Shanghai institute of biochemistry and cell biology. Escherichia coli OP50 and N2 strain of C. elegans was obtained from Caenorhabditis Genetics Center, University of Minnesota, USA. Fetal bovine serum and Dulbecco’s modified Eagle’s medium (DMEM) were purchased from GIBCO Company, USA. Metformin and palmitic acid were bought from Sigma, USA. MTT assay, Oil Red O staining assay, glucose and glycogen contents determination, ATP and TG contents determination, and protein assay kits were purchased from Nanjing Jiancheng Bioengineering Institute, China. TaKaRa MiniBEST Universal RNA extraction kit, PrimeScript™ RT Master Mix kit, and SYBR Premix Ex Taq™ kit were purchased from Takara Bio Company, Japan. All primers were purchased from Sangon Biotech Company, China. All of the other reagents and solvents were purchased from Sinopharm Chemical Reagent Co. Ltd., China and were of either analytical or chromatographic grade.

2.2. BMS Preparation

Unripe bitter melons were washed thoroughly in water and the seeds were removed. Then, the pulp was thinly sliced, freeze-dried, and milled (diameter < 100 μm). Bitter melon powder was added with 75% ethanol for reflux extraction twice at 80°C, and the filtrate was collected. Then, n-butanol saturated with water was applied to extract from the filtrate for 3 times until the concentrated n-butanol phase was brown and sticky. Methanol and acetone were added to produce precipitation, which then was frozen as the BMS.

2.3. HepG2 Cell Culture and HepG2-IR Cell Model

The cells were cultured in monolayers up to 80% confluence in DMEM supplemented with 10% heat-inactivated fetal calf serum and 1% penicillin/streptomycin at 37°C in a humidified incubator supplied with 5% CO_2. Cells in the logarithmic growth phase were used for all the studies described below.

For model of insulin resistance (IR), the supernatant of HepG2 cells inoculated in 96 plates was discarded and replaced with serum-free DMEM medium for 12 hours to keep fasting. Then, the supernatant was discarded, washed twice with PBS, and added with serum-free culture medium containing palmitic acid (the final concentration was 0.25 mM) for 12 hours to induce HepG2-IR cell model.

2.4. Cell Viability and Glucose Consumption Determination

Based on the establishment of HepG2-IR cell model, BMS at different concentrations of 50, 100, 250, 500, 750, 1000, and 2000 μg/L were incubated together with palmitic acid after 12 h fasting. The cell viability was detected by MTT method [10].

For glucose consumption determination, groups were divided into blank group (without cell), normal group, IR model group, and IR model groups with BMS or 2 mM metformin. After 12 h treatment together with palmitic acid, the glucose content determination kit and MTT assay kit were used to measure the glucose consumption, calculated by the following formula:

2.5. Glycogen, TG, and ATP Contents Determination for Cells

For glycogen, TG, and ATP contents determination, groups were divided into normal group, IR model group, IR model groups with BMS or 2 mM metformin. After 12 h treatment together with palmitic acid, the kits for glycogen, TG, ATP, and protein contents determination were applied. Formulas were as the following:

2.6. C. elegans Culture

M9 buffer, S-complete, and nematode growth medium (NGM) used for C. elegans culture were prepared as previously described [11]. Glucose plates were prepared by adding glucose (1M, sterile filtered) into the autoclaved NGM after cooling. Worms were synchronized according to standard protocols [12]. For maintenance, worms were grown on NGM plates and E. coli OP50 was freshly provided as the food source. For assays, C. elegans were treated by ddH₂O or BMS for 48 h from L1 to L4 in the NGM with or without glucose (1 mM final concentration). Groups were divided to normal, model, and model with BMS 100 and 250 μg/L.

2.7. Oil Red O Staining for C. elegans

Synchronized L1 worms were treated with BMS (100 or 250 μg/mL) for 48 h to late L4 stage followed by Oil Red O staining. Oil Red O staining (∼1000 worms per each group) was conducted by washing animals with 1x phosphate-buffered saline (PBS). Worms were washed with 1x PBS three times, fixed with 4% formaldehyde for 15 min and dehydrated with 60% isopropanol for 15 min. Oil Red O solution (0.5 g/100 mL in isopropanol) was diluted in double distilled water to 60% working solution and filtered. Fixed worms were incubated in the working solution overnight at room temperature. Dye was removed after allowing worms to settle, and 200 μL of 1x PBS 0.01% Triton X-100 was added. 20–30 Oil Red O stained worms were randomly selected for imaging with a Leica microscope outfitted with DIC optics (Leica, Wetzlar, Germany) under identical settings and exposure times.

2.8. TG Assay for C. elegans

Synchronized L1 worms were treated with BMS (100 or 250 μg/mL) for 48 h to late L4 stage followed by TG measurement. C. elegans (∼2000 worms per each group) were broken by an ultrasonic cell disrupter and centrifuged to obtain the supernatant. The supernatant was reacted with the kit and the absorbance was measured at a wavelength of 510 nm. The TG and the protein assays were conducted according to the manufacturer’s instructions. TG content was normalized with protein concentration determined by Bradford assay.

2.9. Locomotive Activity, Brood Size, and Lifespan Assay

For head thrashing, worms were washed with M9 buffer and dropped on another NGM plate. The head thrashing frequency (∼30 worms in each group) was observed under a stereo microscope as a change in the direction of bending at the midbody and the number of times was recorded in one minute. The experiment was repeated at least 3 times.

For body bend assay, the examined nematodes (∼30 worms in each group) were picked onto another NGM plate and scored for the times of bodies bends in an interval of 20 sec. A body bend was counted as a change in the direction of the part of nematodes corresponding to the posterior bulb of the pharynx along the y-axis, assuming that nematode was moving along the x-axis. The experiment was repeated at least 3 times.

For brood size, 1 random worm in each group was transferred to a new NGM plate with OP 50, and each group has three duplicates. Worms were transferred to fresh NGM plates during the reproduction period, and the eggs left were allowed to hatch and grow to L4 stage before counting the number of progeny of each worm.

For lifespan, about 100 worms in each group were transferred every day to the corresponding fresh NGM plates from L4 stage until all died. The number of surviving worms were counted and the actual number in the statistical results varies slightly due to the loss of dead or censored animals. Indicators of death included lack of movement, the stress movement of the parasite, and a lack of pharynx contraction after one or two attempts at gentle touching.

2.10. Quantitative Real-Time PCR (qRT-PCR) for Cells and C. elegans

RNA of HepG2 cell and C. elegans samples were extracted by the TaKaRa MiniBEST Universal RNA Extraction Kit. Prime Script™ RT Master Mix Kit was applied to synthesis cDNA according to the manufacturer’s protocol. cDNA was amplified and quantified in a CFX96-PCR detection system using the SYBR Premix Ex Taq II Kit. Primer sequences are listed in Table 1. Data were normalized to GAPDH gene in cells and β-actin gene in C. elegans, analyzed using the △△Ct method [13].

2.11. Statistical Analysis

Data are presented as means ± SE and analyzed with the Statistical Analysis System (SAS Institute, NC, USA). Statistical analysis was performed using one-way analysis of variance, followed by Tukey’s multiple range test to compare between groups. The significance of differences was defined at the level.

3. Results and Discussion

3.1. Influences of BMS on the Cell Viability and Glucose Consumption

Figure 1(a) showed the effect of BMS at different concentrations on the survival rate of HepG2 cells for 12 h. There were no significant effects of BMS concentration from 50 μg/mL to 250 μg/mL on cell viability (), while the concentrations of BMS at 500, 750, 1000, and 2000 μg/mL were obvious (), indicating that BMS concentration greater than 500 μg/mL had a significant inhibitory effect on the cell growth. Therefore, the concentration range of BMSE was determined to be between 50 and 250 μg/mL.

(a)

(b)

The effects of BMS at different concentrations on glucose consumption in HepG2 cells were shown in Figure 1(b). With the palmitic acid induction, the glucose consumption of cells in the model group was significantly lower than that in the normal group (), indicating that the HepG2-IR cell model was successfully established. Similar to the effect of Met, the BMS concentration at 100 and 250 μg/mL, not 50 μg/mL, obviously enhanced the glucose consumption of HepG2 insulin resistant cells (), which was largely due to the stimulation of GLUT4 transferring to the membrane [14].

3.2. BMS Altered the Levels of Glycogen, TG, and ATP in Insulin-Resistance HepG2 Cell

The liver is the main part of the body that regulates blood glucose. As shown in Figure 2(a), the glycogen content in model group was significantly decreased compared to the normal group (), suggesting that the glucose metabolism, especially the gluconeogenesis, was disordered after palmitic acid induction. However, BMS at 100 and 250 μg/mL remarkably normalized the glycogen level of HepG2-IR cells compared with model group, as well as the Met (). Consistent with the results from Min et al. found that triterpenoids isolated from bitter melon could inhibit gluconeogenesis in both L6 myotubes and 3T3-L1 adipocytes to decrease the glucose level [15].

(a)

(b)

(c)

Long-term treatment with palmitic acid in HepG2 cells accelerated the fat accumulation, characterized by the increase of TG level, as shown in Figure 2(b). Supplementation with BMS at 100 and 250 μg/mL concentrations effectively decreased the TG content compared to the model group, suggesting BMS could inhibit the fat deposition of HepG2-IR cells (). In 3T3-L1 cell line, it was reported that bitter melon triterpenoid extract could reduce preadipocyte viability and lipid accumulation [7].

ATP level reflects the status of energy metabolism. Palmitic acid can lead to the uncoupling of mitochondrial respiratory chain of cells and reduce the ATP level, causing the idling state of oxidative phosphorylation [16]. Compared with the normal group, the ATP content in the model group was strikingly declined (). Only BMS at 250 μg/mL exhibited improved ATP level, even not the Met, which illustrated that BMS not only recovered the levels of glycogen and TG, but also improved the disorder of energy metabolism. Metformin failed to increase ATP content, probably due to its abilities to inhibit mitochondrial respiratory chains, therefore reducing ATP production and declining the ratio of ATP/AMP, which in turn activates AMPK [17].

3.3. Effects of BMS on the Expressions of Glucose and Lipid Metabolism Related Genes in HepG2-IR Cells

To discover the potential mechanism of BMS ameliorating the indexes of metabolism, we applied qRT-PCR to check the expressions of related genes. From Figure 3(a), for genes related fatty acid β-oxidation, BMS at 250 μg/mL concentration largely stimulated the mRNA expression of AMPK and CPT1, while decreasing the ACC2 mRNA level (), which enhanced fatty acid β-oxidation [18]. For genes related glucose intake, BMS could augment the expressions of PGC-1α and GLUT4, similar to the effect of Met. Increased GLUT4 translocation from the cytoplasm to the membrane promotes glucose uptake [19]. In line with Han’s study, triterpenoids in bitter melon improved glucose homeostasis by upregulating GLUT4 in streptozotocin‐induced diabetic mice [20]. Based on these results, we speculated the potential pathways of BMS involving in the metabolism included the fatty acid β-oxidation and glucose intake (Figure 3(b)).

(a)

(b)

3.4. BMS Altered the Fat Accumulation of Glucose-Treated C. elegans

C. elegans has been widely used as an in vivo model for exploring the genetic regulation of fat storage, due to the fact that many aspects of fat synthesis and breakdown pathways characterized in humans are conserved in this easy-handling organism [21]. The intestine in C. elegans consists of 20 cells and is responsible for food digestion and nutrient absorption as well as the synthesis and storage of fat [22]. As BMS exhibited strong effects on the lipid metabolism in vitro, we further assessed the impact of BMS on the overall fat and lipid metabolism in C. elegans by Oil Red O staining and TG assay to confirm it. Figure 4 indicated that 1 mM glucose could dramatically stimulate the fat accumulation in C. elegans compared to the normal group, while BMS at both 100 and 250 μg/mL concentrations obviously decreased the overall fat in the body of C. elegans (). Likewise, a striking reduction in TG level was observed in BMS groups than the model group, which further confirmed lipid-lowering efficacy of BMS both in vitro and in vivo.

3.5. Influences of BMS on the Locomotive Activity, Progeny Production, and Longevity in C. elegans

Genetic and environmental factors, including food, have been shown to affect the physical activities of C. elegans and could also play a large role in fat accumulation [21]. Thus, we needed to figure out whether BMS affected the basic growth and development of C. elegans. As shown in Figures 5(a) and 5(b), we found that BMS had no effect on the body bends of C. elegans, but it improved the frequency of head thrashes in glucose-treated worms, which inferred that BMS might slightly enhance the energy expenditure to lower the overall fat. Longevity of C. elegans is closely related with many factors, including environmental, dietary, and genetic factors [23, 24]. High concentration of glucose is shown to exhibit a negative impact on the lifespan of nematodes [25]. Regarding the progeny production and longevity, data suggested that BMS showed no influence on the brood size, while extending the median lifespan of glucose-treated worms, which indicated that both 100 and 250 μg/mL BMS exhibited no toxicity to the growth and development of C. elegans.

(a)

(b)

(c)

(d)

3.6. BMS Regulated the Expressions of Genes Involved in Lipid Metabolism in C. elegans

To discover the potential molecular pathways involved in the effect of BMS on fat reduction, we determined some important genes related lipid metabolism by qRT-PCR. In our current study, we found that BMS treatment profoundly decreased the mRNA expressions of desaturase genes, namely, fat-1, fat-5, and fat-7 (Figure 6), which are known as involved in the de novo synthesis of polyunsaturated fatty acids (PUFAs) [26]. Additionally, we tested a key gene expression involved fatty acid β-oxidation, the nuclear hormone receptor nhr-49 [27]. We found that 1 mM glucose impaired the expression of nhr-49 compared to that in normal group, while BMS significantly upregulated nhr-49 gene expression, indicating that BMS might act on nhr-49 to regulate catabolism of fatty acids by mediating the β-oxidation pathway, thereby reducing fat deposition in C. elegans. This was in accordance with the effects of BMS on enhancing β-oxidation in HepG2 cells.

4. Conclusions

In conclusion, BMS exerted beneficial effects on maintaining energy homeostasis, evidenced by enhancing glucose uptake and consumption in HepG2-IR model through upregulating GLUT4 expression and inhibiting fat accumulation in both HepG2 cell and C. elegans via promoting fatty acid β-oxidation. Prospectively, saponins from bitter melon might be a potential prebiotic to manage clinical patients with obesity or obesity-related metabolic syndrome.

Data Availability

All data generated or analyzed during this study are included in this article.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Acknowledgments

This research was supported by Jiangsu Post-Doctoral Research Funding Program (2020Z070), National Natural Science Foundation of China (31701598), and University Philosophy and Social Science Program (2019SJA1892).

References

Y. C. Chooi, C. Ding, and F. Magkos, “The epidemiology of obesity,” Metabolism, vol. 92, pp. 6–10, 2019.
View at: Publisher Site | Google Scholar
J. Bai, Y. Zhu, and Y. Dong, “Response of gut microbiota and inflammatory status to bitter melon (Momordica charantia L.) in high fat diet induced obese rats,” Journal of Ethnopharmacology, vol. 194, pp. 717–726, 2016.
View at: Publisher Site | Google Scholar
J. Bai, Y. Zhu, and Y. Dong, “Modulation of gut microbiota and gut-generated metabolites by bitter melon results in improvement in the metabolic status in high fat diet-induced obese rats,” Journal of Functional Foods, vol. 41, pp. 127–134, 2018.
View at: Publisher Site | Google Scholar
S. Wang, Z. Li, G. Yang, C.-T. Ho, and S. Li, “Momordica charantia: a popular health-promoting vegetable with multifunctionality,” Food & Function, vol. 8, no. 5, pp. 1749–1762, 2017.
View at: Publisher Site | Google Scholar
J. L. Perez, G. K. Jayaprakasha, and B. S. Patil, “Metabolite profiling and in vitro biological activities of two commercial bitter melon (Momordica charantia Linn.) cultivars,” Food Chemistry, vol. 288, pp. 178–186, 2019.
View at: Publisher Site | Google Scholar
C. Y. Cheok, H. A. K. Salman, and R. Sulaiman, “Extraction and quantification of saponins: a review,” Food Research International, vol. 59, pp. 16–40, 2014.
View at: Publisher Site | Google Scholar
D. G. Popovich, L. Li, and W. Zhang, “Bitter melon (Momordica charantia) triterpenoid extract reduces preadipocyte viability, lipid accumulation and adiponectin expression in 3T3-L1 cells,” Food and Chemical Toxicology, vol. 48, no. 6, pp. 1619–1626, 2010.
View at: Publisher Site | Google Scholar
C.-C. Shih, C.-H. Lin, and W.-L. Lin, “Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet,” Diabetes Research and Clinical Practice, vol. 81, no. 2, pp. 134–143, 2008.
View at: Publisher Site | Google Scholar
X. Xiao, X. Zhang, C. Zhang et al., “Toxicity and multigenerational effects of bisphenol S exposure to Caenorhabditis elegans on developmental, biochemical, reproductive and oxidative stress,” Toxicology Research, vol. 8, no. 5, pp. 630–640, 2019.
View at: Publisher Site | Google Scholar
D. Gerlier and N. Thomasset, “Use of MTT colorimetric assay to measure cell activation,” Journal of Immunological Methods, vol. 94, no. 1-2, pp. 57–63, 1986.
View at: Publisher Site | Google Scholar
G. M. Solis and M. Petrascheck, “Measuring Caenorhabditis elegans life span in 96 well microtiter plates,” Journal of Visualized Experiments, no. 49, 2011.
View at: Publisher Site | Google Scholar
C. Kenyon, J. Chang, E. Gensch, A. Rudner, and R. Tabtiang, “A C. elegans mutant that lives twice as long as wild type,” Nature, vol. 366, no. 6454, pp. 461–464, 1993.
View at: Publisher Site | Google Scholar
K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001.
View at: Publisher Site | Google Scholar
J. O. Lee, S. K. Lee, J. H. Kim et al., “Metformin regulates glucose transporter 4 (GLUT4) translocation through AMP-activated protein kinase (AMPK)-mediated cbl/CAP signaling in 3T3-L1 preadipocyte cells,” Journal of Biological Chemistry, vol. 287, no. 53, pp. 44121–44129, 2012.
View at: Publisher Site | Google Scholar
M.-J. Tan, J.-M. Ye, N. Turner et al., “Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway,” Chemistry & Biology, vol. 15, no. 3, pp. 263–273, 2008.
View at: Publisher Site | Google Scholar
C. Kwon, J. L. Sun, J. H. Jeong, and T. W. Jung, “Humanin attenuates palmitate-induced hepatic lipid accumulation and insulin resistance via AMPK-mediated suppression of the mTOR pathway,” Biochemical and Biophysical Research Communications, vol. 526, no. 2, pp. 539–545, 2020.
View at: Publisher Site | Google Scholar
B. Viollet, B. Guigas, N. S. Garcia, J. Leclerc, M. Foretz, and F. Andreelli, “Cellular and molecular mechanisms of metformin: an overview,” Clinical Science, vol. 122, no. 6, pp. 253–270, 2012.
View at: Publisher Site | Google Scholar
S. Pang, D. A. Lynn, J. Y. Lo, J. Paek, and S. P. Curran, “SKN-1 and NRF2 couples proline catabolism with lipid metabolism during nutrient deprivation,” Nature Communications, vol. 5, no. 1, p. 5048, 2014.
View at: Publisher Site | Google Scholar
Y. Peng, R. Y. Gan, H. B. Li et al., “Absorption, metabolism, and bioactivity of vitexin: recent advances in understanding the efficacy of an important nutraceutical,” Critical Reviews in Food Science and Nutrition, vol. 16, pp. 1–16, 2020.
View at: Publisher Site | Google Scholar
J.-H. Han, N. Q. Tuan, M.-H. Park et al., “Cucurbitane triterpenoids from the fruits of momordica charantia improve insulin sensitivity and glucose homeostasis in streptozotocin-induced diabetic mice,” Molecular Nutrition & Food Research, vol. 62, no. 7, Article ID 1700769, 2018.
View at: Publisher Site | Google Scholar
X. Xiao, C. Tan, X. Sun et al., “Fermented barley β-glucan regulates fat deposition in Caenorhabditis elegans,” Journal of the Science of Food and Agriculture, vol. 100, no. 8, pp. 3408–3417, 2020.
View at: Publisher Site | Google Scholar
L. R. Girard, T. J. Fiedler, T. W. Harris et al., “WormBook: the online review of Caenorhabditis elegans biology,” Nucleic Acids Research, vol. 35, pp. D472–D475, 2007.
View at: Publisher Site | Google Scholar
T. He, L. He, E. Gao et al., “Fat deposition deficiency is critical for the high mortality of pre-weanling newborn piglets,” Journal of Animal Science and Biotechnology, vol. 9, p. 66, 2018.
View at: Publisher Site | Google Scholar
J. Campisi, P. Kapahi, G. J. Lithgow et al., “From discoveries in ageing research to therapeutics for healthy ageing,” Nature, vol. 571, no. 7764, pp. 183–192, 2019.
View at: Publisher Site | Google Scholar
D. J. Eisermann, U. Wenzel, and E. Fitzenberger, “Inhibition of chaperone-mediated autophagy prevents glucotoxicity in the Caenorhabditis elegans mev-1 mutant by activation of the proteasome,” Biochemical and Biophysical Research Communications, vol. 484, no. 1, pp. 171–175, 2017.
View at: Publisher Site | Google Scholar
R. J. S. Reis, L. L. Xu, H. Lee et al., “Modulation of lipid biosynthesis contributes to stress resistance and longevity of C. elegans mutants,” Aging-Us, vol. 3, no. 2, pp. 125–147, 2011.
View at: Publisher Site | Google Scholar
M. R. Van Gilst, H. Hadjivassiliou, and K. R. Yamamoto, “From the cover: a Caenorhabditis elegans nutrient response system partially dependent on nuclear receptor NHR-49,” Proceedings of the National Academy of Sciences, vol. 102, no. 38, pp. 13496–13501, 2005.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2020 Juan Bai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1286

Downloads

968

Citations